1997
DOI: 10.1002/(sici)1098-1101(1997)12:2<68::aid-jca3>3.0.co;2-7
|View full text |Cite
|
Sign up to set email alerts
|

Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: No improvement of the collection efficiency of the Fenwal CS3000 plus during progenitor cell harvests

Abstract: Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: no improvement of the collection efficiency of the Fenwal CS3000 olus during progenitor cell harvests.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1999
1999
2001
2001

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…This CD34+ cell dose not only influences the engraftment kinetics, as patients receiving higher CD34+ cell doses appear to have better hematologic measures at later times after transplantation, 13 but it also facilitates allogeneic transplantation across HLA barriers. In this context, we used the CD34+ cell CE (and not MNC CE) together with the CD34+ cell yield in the component to evaluate the new apheresis technique, because CD34+ cell counts correlate with the engraftment kinetics more closely than MNC counts do, and CD34+ cell CE does not always correlate with MNC CE 14 . On the basis of the favorable low platelet CEs in the AutoPBSC shown in this article, our group has changed the criteria for starting leukapheresis from 70,000 platelets per μL 15 to ≥25,000 platelets per μL, which allows us to carry out successful collection of CD34+ HPCs in heavily treated “poor‐mobilizer” and thrombocytopenic patients.…”
Section: Discussionmentioning
confidence: 99%
“…This CD34+ cell dose not only influences the engraftment kinetics, as patients receiving higher CD34+ cell doses appear to have better hematologic measures at later times after transplantation, 13 but it also facilitates allogeneic transplantation across HLA barriers. In this context, we used the CD34+ cell CE (and not MNC CE) together with the CD34+ cell yield in the component to evaluate the new apheresis technique, because CD34+ cell counts correlate with the engraftment kinetics more closely than MNC counts do, and CD34+ cell CE does not always correlate with MNC CE 14 . On the basis of the favorable low platelet CEs in the AutoPBSC shown in this article, our group has changed the criteria for starting leukapheresis from 70,000 platelets per μL 15 to ≥25,000 platelets per μL, which allows us to carry out successful collection of CD34+ HPCs in heavily treated “poor‐mobilizer” and thrombocytopenic patients.…”
Section: Discussionmentioning
confidence: 99%
“…Different cell densities amongst the leukocyte population allow the collection of the mononuclear cell fraction by means of centrifugation and separation. Optimal adjustment of the cell separator increases the collection efficiency and purity of the apheresis products [7,8]. Nevertheless, it is well known that the purity of mononuclear cells is limited by the contamination of platelets, neutrophil granulocytes and erythrocytes.…”
Section: Introductionmentioning
confidence: 99%